FDA Clearance of CBC Marks a Defining Platform Milestone, Expanding TruVerus™ to 26 Cleared Assays and the First FDA ...

The company outlined progress on its anticoagulation pipeline, including its HIT program VLX-1005, at a Lytham Partners ...

Treatments for are allergic fungal rhinosinusitis, bipolar I disorder, Hunter syndrome, Leber hereditary optic neuropathy, ovarian cancer, and schizophrenia under review.

Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today highlighted the ...

The drug targets a specific mutation that applies to only 2% of ALS patients. A new drug may slow progression of -- and even reverse -- symptoms of a rare form of amyotrophic lateral sclerosis, or ALS ...

President Donald Trump signed an executive order Thursday reclassifying marijuana as a less dangerous drug — a move expected to ease restrictions so it's easier to purchase and sell, and pave the way ...

President Donald Trump has signed an executive order making some big changes to marijuana policy, the most substantial since 1970. On Dec. 18, Trump ordered the government to stop classifying ...

Medicare drug price negotiations kick-started by the Biden administration will finally result in lower drug prices for seniors beginning Jan. 1. The Medicare-negotiated price cuts will apply to 10 ...

Aaron Navarro is a CBS News digital reporter. He covered the 2024 elections and was previously an associate producer for the CBS News political unit in the 2021 and 2022 election cycles. Washington — ...

Last month, the U.S. Senate narrowly rejected a bipartisan resolution recently that would have prevented the Trump administration from launching military strikes in Venezuela without congressional ...